Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology

Gretchen Henkel  |  Issue: October 2012  |  October 1, 2012

Dr. Scofield recalls many late afternoon sessions “planning and discussing our science. He set the tone that the program should be collegial and interactive.” Enjoyment of each other’s company was also part of the recipe. Dr. Harley recalls annual chili cook-offs every February in honor of Dr. Reichlin’s birthday, and during holiday gatherings at the Reichlin home, Drs. Scofield and Reichlin were known to perform on their trumpets (see photo at right). “I’m a social character,” says Dr. Reichlin. “I like to interact with people, and I feel that organizational skills are important in moving a field forward. So it came naturally and easily to me.”

Legacy of Generosity

“There wasn’t anyone who had more influence on my career than he did,” Dr. Targoff now says of his long-term association with Dr. Reichlin. After residency, he joined Dr. Reichlin’s research program in Buffalo. Then, when it was time to establish his own lab, Dr. Reichlin “made that transition very easy for me. He was also a good role model for academic medicine.” Currently, Dr. Targoff is an assistant member with the Arthritis and Clinical Immunology Research Program and professor of medicine at OHSC, and a staff physician with the Oklahoma City Veterans Affairs Medical Center.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Yasuhiko Itoh, MD, PhD, of the department of pediatrics at Nippon Medical School in Tokyo, did his postdoctoral work in rheumatology at OMRF from 1988 to 1991. “As a supervisor, Dr. Reichlin was incredibly patient and very good at praising young people. During my first month in the lab, I repeatedly failed Western blots. When I finally succeeded, he told me, ‘You are the King of Gel!’ ” Exposure to Dr. Reichlin’s autoantibody discoveries and research values have continued to influence Dr. Itoh’s own work, as he continues to try, he says, to “solve patients’ symptoms as scientifically as possible.”

Dr. Scofield notes, “Moe was always really generous with everybody, always wanting to collaborate and to nurture the next generation.” That trend has continued. In 2007, Yehuda Shoenfeld, MD, head of the Zabludowicz Center for Autoimmune Diseases in the Sheba Medical Center and Tel-Aviv University, Israel, whose laboratory is well known for experimental models of induced autoimmune disease, was interested in investigating the psychiatric manifestations of lupus. He contacted Dr. Reichlin, who immediately agreed to send purified anti-P ribosomal antibodies for the experiments, which involved injection of the autoantibodies directly to the brain to bypass the blood–brain barrier. The mice developed depression. In follow-up investigations, Dr. Reichlin helped to identify the limbic system as associated with both depression and sense of smell.6 Thus, Dr. Reichlin’s generosity and inquisitiveness “were instrumental in identifying the autoimmune mechanism responsible for psychiatric manifestations, and led to the new field that we later developed about smell and the autoimmune diseases,” says Dr. Shoenfeld.7

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingProfessional TopicsProfilesResearch RheumSjögren’s Disease Tagged with:Immunologyinflammatory myopathypatient careProfileResearchrheumatologistSclerodermaSjogren'sSystemic lupus erythematosus

Related Articles

    In Memoriam: Morris Reichlin, MD

    September 20, 2018

    With sadness we honor the passing of Morris Reichlin, MD. Dr. “Moe” Reichlin enjoyed a distinguished clinical, investigative, rheumatology career that spanned more than five decades. Moe was inquisitive, persistent, humble and inspiring. His achievements were many and diverse. Moe Reichlin received his BA and MD degrees from Washington University in St. Louis, where he…

    The 2020 ARP Merit Awards & ACR Distinguished Fellows

    December 14, 2020

    During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…

    2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed

    February 1, 2014

    New research clarifies signs of rheumatoid arthritis and systemic lupus erythematosus years in advance and could lead to presymptomatic treatment intervention

    Search for Infectious Triggers of Rheumatic Disease Could Yield Options to Block Process

    January 19, 2016

    SAN FRANCISCO—Two hundred years ago, physicians knew nothing about what caused various forms of arthritis. Today, we have more clues about what may trigger rheumatic diseases, but still can’t pinpoint the culprits that set scores of inflammatory conditions in motion. Researchers discussed some of the background and recent findings that point to what immunologists call…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences